These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Congestion as a therapeutic target in acute heart failure syndromes. Goldsmith SR; Brandimarte F; Gheorghiade M Prog Cardiovasc Dis; 2010; 52(5):383-92. PubMed ID: 20226956 [TBL] [Abstract][Full Text] [Related]
5. Vasopressin antagonists for the treatment of acute decompensated heart failure: when, for whom, for how long, and on what standard therapy? Filippatos G; Parissis JT J Card Fail; 2008 Oct; 14(8):648-50. PubMed ID: 18926435 [No Abstract] [Full Text] [Related]
6. Managed care interventions for improving outcomes in acute heart failure syndromes. Khan SS; Gheorghiade M; Dunn JD; Pezalla E; Fonarow GC Am J Manag Care; 2008 Dec; 14(12 Suppl Managed):S273-86; quiz S287-91. PubMed ID: 19166273 [TBL] [Abstract][Full Text] [Related]
7. Acute heart failure syndromes and coronary perfusion. Beohar N; Erdogan AK; Lee DC; Sabbah HN; Kern MJ; Teerlink J; Bonow RO; Gheorghiade M J Am Coll Cardiol; 2008 Jul; 52(1):13-6. PubMed ID: 18582629 [TBL] [Abstract][Full Text] [Related]
8. Congestion in acute heart failure syndromes: importance of early recognition and treatment. De Luca L; Abraham WT; Fonarow GC; Gheorghiade M Rev Cardiovasc Med; 2006; 7(2):69-74. PubMed ID: 16915125 [TBL] [Abstract][Full Text] [Related]
9. Acute heart failure syndromes: highlights from the ESC Working Group on Acute Cardiac Care Meeting Prague, Czech Republic 2006. Harinstein ME; Gheorghiade M Acute Card Care; 2006; 8(4):179-80. PubMed ID: 17162543 [No Abstract] [Full Text] [Related]
10. Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. Flaherty JD; Bax JJ; De Luca L; Rossi JS; Davidson CJ; Filippatos G; Liu PP; Konstam MA; Greenberg B; Mehra MR; Breithardt G; Pang PS; Young JB; Fonarow GC; Bonow RO; Gheorghiade M; J Am Coll Cardiol; 2009 Jan; 53(3):254-63. PubMed ID: 19147042 [TBL] [Abstract][Full Text] [Related]
11. Vasopressin and vasopressin receptor antagonists in heart failure. Oghlakian G; Klapholz M Cardiol Rev; 2009; 17(1):10-5. PubMed ID: 19092365 [TBL] [Abstract][Full Text] [Related]
12. [Rational use of catecholamines and inotropes]. Hewing B; Stangl K Pneumologie; 2007 Nov; 61(11):700-8. PubMed ID: 17929214 [TBL] [Abstract][Full Text] [Related]
13. The role of antidiuretic hormone in the pathophysiology and treatment of heart failure. Piçarra BC; Dionísio P; Jara A Rev Port Cardiol; 2009 Sep; 28(9):971-83. PubMed ID: 19998808 [TBL] [Abstract][Full Text] [Related]
14. EVEREST study: Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan. Cavalcante JL; Khan S; Gheorghiade M Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1331-8. PubMed ID: 19018685 [TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of volume overload in acute heart failure syndromes. Chen HH; Schrier RW Am J Med; 2006 Dec; 119(12 Suppl 1):S11-6. PubMed ID: 17113395 [TBL] [Abstract][Full Text] [Related]
16. Arginine vasopressin receptor antagonists for heart failure: a winter climbing to the Everest's tip? Rossi GP J Am Coll Cardiol; 2007 Jun; 49(22):2160-2. PubMed ID: 17543635 [No Abstract] [Full Text] [Related]
17. [Use of vasopressin analogues and antagonist in clinical practice]. Królczyk J; Nizankowski R; Grodzicki T Folia Med Cracov; 2004; 45(1-2):91-6. PubMed ID: 16276829 [TBL] [Abstract][Full Text] [Related]